Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.

The opinion is based on positive data from the phase 3 Balance study, which showed a significant reduction of triglycerides ...

Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the brain, a research group led by Osaka Metropolitan University Associate ...

Giant cell arteritis (GCA) is the most frequent primary systemic vasculitis in adults, involving medium-to-large-sized ...

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

Thinning hair has many possible causes, and understanding why it happens is the key to successful treatment. An expert guide ...

The presentations will highlight the objectives and design of the company's upcoming Phase 3 clinical trial in acute ischemic stroke (AIS), RESTORE, as well as a new post hoc analysis from its ...

Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the ...

Table of Contents The Simple Approach That Finally Worked for Me Why Timing Your Recovery Actually Matters Easy Ways to […] ...

"In August and September, there are probably still going to be ... large numbers of deaths because children have already ...